FIELD: medicine.
SUBSTANCE: group of inventions relates to strain Lactococcus lactis CNCM I-2807, intended for treatment or prevention of digestion disorder, and its application. Strain Lactococcus lactis CNCM I-1631 can also be applied for treatment or prevention of digestion disorder. Diameters of zones of inhibiting pathogenic organisms E. coli, L. monocytogenes and S. enteritidis in incubation with strain Lactococcus lactis CNCM I-1631 constitute more than 6 mm. After 4 hours of incubation with apical part of monolayer of T84 cells value of transepithelial electric resistance constitutes 108.54% for strain Lactococcus lactis CNCM I-2807 and 110.90% for strain Lactococcus lactis CNCM I-1631.
EFFECT: group of inventions provides inhibition of growth of pathogenic microorganisms, improvement of intestine epithelial barrier integrity.
6 cl, 2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DIGESTIVE AGENT | 2015 |
|
RU2708146C2 |
| PROBIOTIC COMPOSITION CONTAINING STRAINS OF LACTOBACILLUS RHAMNOSUS AND LACTOBACILLUS PARACASEI | 2016 |
|
RU2744271C2 |
| LACTOBACILLUS MUCOSAE STRAIN FOR PRODUCING FERMENTED FOOD PRODUCTS | 2011 |
|
RU2606770C2 |
| STRAIN Lactobacillus rhamnosus POSSESSING ANTIMICROBIAL, IMMUNOMODULATORY AND MANNOSE-SPECIFIC ADHESION PROPERTIES, AS WELL AS BASED PRODUCT | 2009 |
|
RU2549699C2 |
| USING LACTOBACILLUS PARACASEI CNCM I-2116 TO TREAT IRRITABLE BOWEL SYNDROME | 2003 |
|
RU2490325C2 |
| COMPOSITIONS AND METHODS FOR INCREASING OR MAINTAINING ABUNDANCE OF FAECALIBACTERIUM PRAUSNITZII | 2015 |
|
RU2712568C2 |
| COMPOSITION FOR REDUCING INTESTINAL GAS PRODUCTION | 2015 |
|
RU2725883C2 |
| PROBIOTICS FOR INTESTINE NEUROMUSCULAR FUNCTION | 2003 |
|
RU2346036C2 |
| USE OF CAROTENOID OF MICROBIAL ORIGIN THAT AFFECTS COMPOSITION OF INTESTINAL MICROORGANISMS | 2017 |
|
RU2759600C2 |
| PROBIOTIC COMPOSITION FOR APPLICATION IN TREATMENT OF INTESTINAL INFLAMMATION | 2011 |
|
RU2563525C2 |
